[1]刘宇航,张永明,王建华. 唑来磷酸钠联合骨化三醇治疗原发性骨质疏松症的疗效观察[J].中华老年骨科与康复电子杂志,2019,(04):206-210.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.04.005]
 Liu Yuhang,Zhang Yongming,Wang Jianhua.. Observation of curative effect of zolai sodium phosphate combined with trialcohol in treatment of primary osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(04):206-210.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.04.005]
点击复制

 唑来磷酸钠联合骨化三醇治疗原发性骨质疏松症的疗效观察
()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2019年04期
页码:
206-210
栏目:
论著
出版日期:
2019-08-05

文章信息/Info

Title:
 Observation of curative effect of zolai sodium phosphate combined with trialcohol in treatment of primary osteoporosis
作者:
 刘宇航 张永明 王建华
作者单位:300457 天津市泰达医院骨二科
Author(s):
 Liu Yuhang Zhang Yongming Wang Jianhua.
 Department of Orthopedic, Tianjin TEDA Hospital, Tianjin 300457, China
关键词:
 【关键词】 骨质疏松症 唑来磷酸钠 骨化三醇
Keywords:
 【Key words】 Osteoporosis Zoledronic Acid Calcitriol
DOI:
DOI:10.3877/cma.j.issn.2096-0263.2019.04.005
文献标志码:
A
摘要:
 【摘要】 目的 探讨唑来磷酸钠联合骨化三醇治疗骨质疏松症的临床效果。方法 前瞻性收集2012年10月至2017年10月天津市泰达医院收治的203例骨质疏松症患者,采用随机数字表法将其分为唑来磷酸钠组(A组)和唑来磷酸钠联合骨化三醇(B组),A组102例,B组101例,比较两组患者治疗前后的骨密度变化、骨代谢情况、不良反应等情况。结果 203例患者均获得完整随访,随访率100%,随访时间3~5年,平均(3.9±0.5)年。治疗前两组患者的髋部骨密度[A组(0.557±0.052)g/cm3,B组(0.554±0.056)g/cm3]、腰椎骨密度[A组(0.669±0.047)g/cm3,B组(0.670±0.047)g/cm3]无明显差异,治疗后腰椎骨密度水平[A组(0.863±0.023)g/cm3,B组(0.870±0.021)g/cm3]均有显著改善,与治疗前相比,差异均有统计学意义(t=38.661,t=38.152,P<0.05),髋部骨密度水平均有改善[A组(0.720±0.023)g/cm3,B组(0.750±0.044)g/cm3],与治疗前相比,差异均有统计学意义(t=28.653,t=32.533,P<0.05),治疗后组间差异有统计学意义(t=2.001,t=5.921,P<0.05);两组患者治疗前血钙指标[A组(2.200±0.059)mmol/L,B组(2.201±0.054)mmol/L]无明显差异,治疗后[A组(2.211±0.060)mmol/L,B组(2.323±0.044)mmol/L]B组血钙变化明显,与A组比较差异有统计学意义(P<0.05)。B组(15.8%)的不良反应发生率低于A组(33.3%),两组患者均无严重药物不良反应发生。结论 唑来磷酸钠联合骨化三醇可提高骨质疏松患者骨密度,改善骨代谢状态,并且降低药物不良反应的发生率。
Abstract:

【Abstract】 Objective To investigate the clinical effect of sodium zoledronate combined with calcitriol in the treatment of osteoporosis. Methods A prospective study of 203 patients with osteoporosis admitted to Tianjin TEDA Hospital from October 2012 to October 2017 was divided into three groups: the sodium zoledronate group (group A) and the combination of sodium zoledronate. Calcitriol (group B), 102 patients in group A and 101 patients in group B. The changes of bone mineral density, bone metabolism and adverse reactions were observed before and after treatment. All the 203 patients had been followed, The rate was 100% and lasted 3-5 years (3.891±0.501 on average). There was no significant difference in bone mineral density of the hip [group A (0.557±0.052) g/cm3,group B (0.554±0.056) g/cm3] and the lumbar vertebrae [group A (0.669±0.047) g/cm3,group B (0.670±0.047) g/cm3] between the two groups before treatment. The bone mineral density of the lumbar vertebrae improved after treatment [group A (0.863±0.023) g/cm3, group B (0.870±0.021) g/cm3], compared with before treatment, the difference was statistically significant (t=38.661, t=38.152, P<0.05). The hip bone mineral density level was improved [group A (0.720±0.023) g/cm3, group B (0.750±0.044) g/cm3],compared with before treatment, the difference was statistically significant (t=28.653, t=32.533, P<0.05). There was significant difference between the two groups after treatment (t=2.001, t=5.921, P<0.05), there was no significant difference in blood calcium index between the two groups before treatment [group A (2.200±0.059) mmol/L, group B (2.201±0.054) mmol/L]. The blood calcium in group B was significantly changed after treatment [group A (2.211±0.060) mmol/L, group B (2.323±0.044) mmol/L], and the difference was statistically significant (P<0.05). The incidence of adverse reactions in group B (15.8%) was lower than that in group A (33.3%), and no serious adverse drug reactions occurred in either group. Conclusion Sodium zoledronate combined with calcitriol can increase bone mineral density, improve bone metabolism and reduce the incidence of adverse drug reaction-s in patients with osteoporosis.

参考文献/References:

1 Abe Y, Iba K, Sasaki K, et al. Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice [J]. J Bone Miner Metab, 2015, 33(2): 125-134.
2 Han SL, Wan SL. Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials [J]. Int J Clin Pract, 2012, 66(2): 199-209.
3 Carmel AS, Shieh A, Bang H, et al. The 25(OH)D level needed to maintain a favorable bisphosphonate response is≥33 ng/ml [J]. Osteoporos Int, 2012, 23(10): 2479-2487.
4 Peris P, Martínez-Ferrer A, Monegal A, et al. 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis [J]. Bone, 2012, 51(1): 54-58.
5 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group [J]. Osteoporos Int, 1994, 4(6): 368-381.
6 冯燕茹, 黄庆森. 老年性骨质疏松症诊断的进展 [J]. 中国骨伤, 2001, 14(11): 42-44.
7 Xia WB, He SL, Xu L, et al. Rapidly increasing rates of hip fracture in Beijing, China [J]. J Bone Miner Res, 2012, 27(1): 125-129.
8 Dai K, Zhang Q, Fan T, et al. Estimation of resource utilization associated with osteoPorotichiP fracture and level ofPost-acute care in China [J]. Curr Med Res Opin, 2007, 23(12): 2937-2943.
9 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南 [J]. 中华骨质疏松和骨矿盐疾病杂志, 1994, 10(5): 51-52.
10 陆琳松, 孙俊刚, 钟惠琴, 等. 唑来膦酸对新疆哈萨克族老年男性骨质疏松患者的疗效观察 [J]. 中国药物与临床, 2015, 15(11): 1553-1556.
11 张青, 赵蓓初, 李建力. 唑来磷酸钠的药理作用及临床应用 [J]. 实用临床医药杂志, 2006, 10(4): 132-134.
12 Pan B, To LB, Farrugia AN, et al. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cels in vitro [J]. Bone, 2004, 34(1): 112-123.
13 程义勇. 《中国居民膳食营养素参考摄入量》2013修订版简介 [J]. 营养学报, 2014, 36(4): 313-317.
14 冯和林, 王进, 许建发, 等. 椎体后凸成形术联合唑来磷酸钠治疗骨质疏松性椎体压缩骨折的临床疗效 [J]. 河北医药, 2016, 38(13): 1953-1956.
15 翟翠云, 王洪光. 骨化三醇的临床应用与不良反应 [J]. 中国医药技术经济与管理, 2008, 2(9): 69-72.
16 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中国全科医学, 2017, 20(32): 3963-3982.
17 付强, 刘源. 钙、磷与维生素D对动物骨代谢的影响研究进展 [J]. 中国比较医学杂志, 2006, 16(8): 502-505.
18 Gardiner EM, BaldockPA, Thomas GP, et al. Increased formation and decreased resorPtion of bone in mice with elevated vitamin DrecePtor in mature cells of the osteoblastic lineage [J]. FASEB J, 2000, 14(13): 1908-1916.
19 Kveiborg M, Rattan SI, Clark BF, et al. Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture [J]. J Cell Physiol, 2001, 186(2): 298-306.
20 宁志伟. 维生素D与骨质疏松症 [J]. 中国医学前沿杂志:电子版, 2015, 7(10): 8-14.
21 Catalano A, Morabito N, Atteritano M, et al. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis [J]. Calcif Tissue Int, 2012, 90(4): 279-285.

相似文献/References:

[1]鲍飞龙 刘涛 亢世杰 黄东生 江涛 胡义明. 双反牵引装置治疗Schatzker分型Ⅴ、Ⅵ型胫骨平台骨折的优势[J].中华老年骨科与康复电子杂志,2018,(05):266.
 Bao Feilong,Liu Tao,Kang Shijie,et al.The advantage of homeopathic double reverse traction device treating tibial plateau fractures of typing Schatzker Ⅴ and Ⅵ[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(04):266.
[2]王哲培 张凯 保罗 汪毅 白震民. 太极拳对老年女性下肢静态平衡、本体感觉与功能活动的影响[J].中华老年骨科与康复电子杂志,2018,(05):296.
 Wang Zhepei,Zhang Kai,Pablo,et al. The influence of Taijiquan on the lower limbs static balance, proprioception and functional activities of older women[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(04):296.
[3]刘磊 王宝泉 孙然 杨宗酉 孙家元 陈伟 王海立 殷兵 刘松 李石伦 杨光 张英泽. 2010年至2011年中国东部和西部地区成人股骨转子间骨折流行病学对比分析[J].中华老年骨科与康复电子杂志,2018,(05):302.
 Liu Lei,Wang Baoquan,Sun Ran,et al.Epidemiological comparison of adult femoral intertrochanteric fractures between the east and west areas in China from 2010 through 2011[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(04):302.
[4]吴石磊 刘勇 邵增务 田青. 骨组织细胞外泌体对骨代谢作用的研究现状[J].中华老年骨科与康复电子杂志,2018,(05):308.
 Wu Shilei,Liu Yong,Shao Zengwu,et al. Research status of bone tissue-derived exosomes on bone metabolism[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(04):308.
[5]张世峰 金群华. 胫骨高位截骨术治疗膝内侧单间室骨关节炎的研究进展[J].中华老年骨科与康复电子杂志,2018,(05):312.
 Zhang Shifeng,Jin Qunhua.. Research progress of high tibial osteotomy in the treatment of medial single compartment osteoarthritis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(04):312.
[6]赵永辉,陆声,马宇龙,等. 皮质骨通道螺钉技术在腰椎退变性疾病中的临床应用[J].中华老年骨科与康复电子杂志,2019,(03):123.[doi:10.3877/cma.j.issn.2096-0263.2019.001]
 Zhao Yonghui,Lu Sheng,Ma Yulong,et al. Clinical application of cortical bone screw technique in elderly patients with lumbar degenerative diseases[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(04):123.[doi:10.3877/cma.j.issn.2096-0263.2019.001]
[7]王虎 李明 靳泽岳 连晓东 陈伟. 不同方法治疗老年股骨转子间合并转子下骨折的比较[J].中华老年骨科与康复电子杂志,2019,(03):135.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.003]
 Wang Hu,Chen Wei.. Comparative of different methods for the treatment of intertrochanteric-subtrochanteric fracture[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(04):135.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.003]
[8]明立功 孟维娜 明朝戈 栗贡策 王自方 王新德 明立山 许振华.腓骨近端截骨联合中医药治疗膝关节内侧间室骨关节炎肝肾不足、气滞血瘀证[J].中华老年骨科与康复电子杂志,2019,(03):149.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.005]
 Ming Ligong,Meng Weina,Ming Chaoge,et al. Proximal fibular osteotomy combined with traditional Chinese medicine in the treatment of osteoarthritis of medial compartment of knee joint with liver and kidney insufficiency, qi stagnation and blood stasis syndrome[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(04):149.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.005]
[9]胡建平 李俊峰 秦鸿雁 张强 张卫国 陈明. 长短髓内钉治疗老年股骨反转子间骨折的疗效比较[J].中华老年骨科与康复电子杂志,2019,(03):143.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.004]
 Hu Jianping,Li Junfeng,Qin Hongyan,et al. Comparison of short intramedullary nail and long intramedullary nail for the treatment of reverse oblique intertrochanteric fractures in the elderly[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(04):143.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.004]
[10]魏宁 常文利 杜晨光 侯志勇 张世强 焦振清 李增炎 陈伟 张英泽. 河北医科大学第三医院956例后踝骨折的流行病学分析[J].中华老年骨科与康复电子杂志,2019,(03):167.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.008]
 Wei Ning,Chang Wenli,Du Chenguang,et al. The retrospective analysis of 956 cases with posterior malleolar fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(04):167.[doi:DOI:10.3877/cma.j.issn.2096-0263.2019.008]

备注/Memo

备注/Memo:

基金项目:国家自然科学基金(30772193)
更新日期/Last Update: 2019-09-19